Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)

Abstract

Regarding this t4 report, which appeared in ALTEX (2013), 30(2), as co-author Thomas Hartung would like to acknowledge that the respective patents referred to, which he holds as the co-inventor of the whole blood pyrogen test, were at the time of the article licensed to Biotest Pharmaceuticals, Germany, and he received royalties from sales of this test. The license and associated royalty payment obligations were in the meantime transferred to Merck-Millipore, France.